Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy

Clinical trial NCT02770261 · COMPLETED

Trial details

NCT number: NCT02770261
Sponsor: Alvogen Korea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension Cholesterolemia

Start date: 2015-12-01
Primary completion: 2016-08-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.